Scotia Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.99M Buy
47,292
+1,887
+4% +$406K 0.04% 214
2025
Q4
$9.33M Sell
45,405
-3,260
-7% -$614K 0.04% 216
2025
Q3
$7.64M Sell
48,665
-12,692
-21% -$1.96M 0.03% 234
2025
Q2
$10.3M Buy
61,357
+2,860
+5% +$424K 0.05% 191
2025
Q1
$8.06M Buy
58,497
+1,165
+2% +$149K 0.04% 210
2024
Q4
$6.78M Buy
57,332
+1,678
+3% +$196K 0.04% 221
2024
Q3
$6.15M Sell
55,654
-6,947
-11% -$726K 0.03% 232
2024
Q2
$6.15M Sell
62,601
-1,667
-3% -$170K 0.04% 223
2024
Q1
$7.19M Buy
64,268
+43,255
+206% +$4.67M 0.04% 205
2023
Q4
$2.12M Sell
21,013
-835
-4% -$82.8K 0.01% 346
2023
Q3
$1.9M Buy
21,848
+17,472
+399% +$1.58M 0.01% 348
2023
Q2
$414K Buy
4,376
+214
+5% +$18.1K ﹤0.01% 583
2023
Q1
$314K Buy
4,162
+1,176
+39% +$88.7K ﹤0.01% 626
2022
Q4
$230K Buy
+2,986
New +$227K ﹤0.01% 690
2022
Q3
Sell
-25,074
Closed -$1.31M 787
2022
Q2
$1.31M Sell
25,074
-1,098
-4% -$62.4K 0.01% 422
2022
Q1
$1.48M Buy
26,172
+1,041
+4% +$55.8K 0.01% 447
2021
Q4
$1.29M Sell
25,131
-13,218
-34% -$648K 0.01% 486
2021
Q3
$1.9M Buy
38,349
+15,134
+65% +$821K 0.01% 402
2021
Q2
$1.32M Buy
23,215
+5,299
+30% +$310K 0.01% 465
2021
Q1
$1.09M Sell
17,916
-3,798
-17% -$210K 0.01% 468
2020
Q4
$1.16M Sell
21,714
-842
-4% -$43.7K 0.01% 409
2020
Q3
$1.06M Sell
22,556
-17,111
-43% -$878K 0.01% 388
2020
Q2
$2.07M Buy
39,667
+1,605
+4% +$82.7K 0.03% 259
2020
Q1
$1.82M Buy
38,062
+24,376
+178% +$1.27M 0.03% 258
2019
Q4
$692K Buy
13,686
+1,460
+12% +$75.4K 0.01% 458
2019
Q3
$577K Buy
12,226
+1,236
+11% +$56.4K 0.01% 487
2019
Q2
$518K Buy
10,990
+1,261
+13% +$58.2K 0.01% 513
2019
Q1
$468K Buy
9,729
+1,913
+24% +$95.8K 0.01% 510
2018
Q4
$349K Buy
+7,816
New +$407K 0.01% 518
2018
Q1
Sell
-26,958
Closed -$1.65M 706
2017
Q4
$1.65M Buy
+26,958
New +$1.67M 0.02% 328
2017
Q3
Sell
-4,108
Closed -$320K 705
2017
Q2
$320K Buy
4,108
+456
+12% +$34.4K 0.01% 556
2017
Q1
$298K Sell
3,652
-4,742
-56% -$373K 0.01% 598
2016
Q4
$604K Buy
8,394
+2,978
+55% +$215K 0.01% 529
2016
Q3
$421K Sell
5,416
-1,612
-23% -$130K 0.01% 592
2016
Q2
$548K Buy
+7,028
New +$560K 0.01% 506
2016
Q1
Sell
-7,321
Closed -$654K 704
2015
Q4
$654K Hold
7,321
0.01% 503
2015
Q3
$564K Buy
+7,321
New +$612K 0.01% 515

Other funds holding CAH

Scotia Capital's CAH Position: Q1 2026 in Review

Scotia Capital increased its Cardinal Health (CAH) stake by 4.2% in Q1 2026, buying an estimated $406K and bringing the position to 47,292 shares worth $9.99M. The position accounts for 0.04% of the portfolio, ranked #214.

Scotia Capital first reported a position in CAH in Q3 2015 and has held it in 37 quarters since. The position peaked at $10.3M in Q2 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Scotia Capital held 47,292 shares of Cardinal Health worth $9.99M as of Q1 2026.
  • Scotia Capital bought 1,887 Cardinal Health shares in Q1 2026, an estimated $406K.
  • Cardinal Health made up 0.04% of Scotia Capital's portfolio in Q1 2026, its #214 holding.
  • Scotia Capital first reported a position in Cardinal Health in Q3 2015 and has held it in 37 quarters since.
  • Scotia Capital's Cardinal Health position peaked at $10.3M in Q2 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.